📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial. (2015)

First Author: MacDonald TM

Attributed to: Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2015-007645

PubMed Identifier: 26253566

Publication URI: http://europepmc.org/abstract/MED/26253566

Type: Journal Article/Review

Volume: 5

Parent Publication: BMJ open

Issue: 8

ISSN: 2044-6055